January 4, 2026- Our review article is published on Journal of Biomedical Science, reporting microbiome modulation of tumorigenesis and immune responses. Congratulations to all the authors, in particular to the first author, Yuning (Christine) Chen, and the co-corresponding author, Yan-Ruide […]
November 18, 2025- Our PhD student, James Elsten-Brown, receives the distinguished John W. Phillips Legacy Award that recognizes exceptional achievements in research, teaching, and mentoring. Congratulations! [UCLA MIMG News PDF] June 10, 2025- Our PhD student, John Yichen Zhu, receives […]
May 30, 2024- Dr. Lili Yang receives a $6.3 million CIRM Partnering Opportunity for Translational Research Projects Award to translate a novel stem cell-engineered off-the-shelf CAR-NKT cell therapy for ovarian cancer into clinics. [Link][PDF] May 18, 2021- Dr. Lili Yang […]
We are currently recruiting PhD students (2 openings) and postdoctoral researchers (1 opening). Welcome to apply! [PhD Openings][Postdoc Openings]
May 11, 2021- Our off-the-shelf cell therapy technology is licensed by a Biotech startup, Appia Bio, for commercial development. The company launches with $52 million Series A financing. [Appia News][Endpoints News] August 5, 2021- Appia Bio and Kite announce collaboration […]
Our paper is published on Science Immunology, reporting the identification of monoamine oxidase A (MAO-A) as an immune checkpoint restraining antitumor T cell immunity and the repurposing of MAO inhibitor (MAOI) antidepressants for cancer immunotherapy. Congratulations to all the authors, […]
Our JEM paper reporting creatine uptake regulation of CD8 T cell immunity is featured on UCLA News and other media. [PDF][UCLA News][UC News][MedicalXpress][ScienceDaily][The Medical News][Technology Networks]
Our paper reporting creatine uptake regulation of CD8 T cell immunity is published online on the Journal of Experimental Medicine. Congratulations to all the authors, in particular to the co-first authors Stefano Di Biase & Jessie Xiaoya Ma! [Link]
Our Cell Stem Cell paper reporting HSC-engineered iNKT cell therapy is featured on the journal’s October issue for “In Translation”. [link]
Our Cell Stem Cell paper reporting HSC-engineering iNKT cell cancer therapy is featured on UCLA News and other media. [PDF][UCLA News][Medical News Today][The Stem Cell Podcast]
Next Page »
